{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T02:57:34Z","timestamp":1771210654689,"version":"3.50.1"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Patients from racially and ethnically minoritized populations, such as Black and Hispanic patients, may be less likely to receive evidence-based COVID-19 treatments than White patients, contributing to adverse clinical outcomes.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether clinical treatments and outcomes among patients hospitalized with COVID-19 were associated with race.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study was conducted in 130 Department of Veterans Affairs Medical Centers (VAMCs) between March 1, 2020, and February 28, 2022, with a 60-day follow-up period until May 1, 2022. Participants included veterans hospitalized with COVID-19. Data were analyzed from May 6 to June 2, 2022.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Self-reported race.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Clinical care processes (eg, intensive care unit [ICU] admission; organ support measures, including invasive and noninvasive mechanical ventilation; prone position therapy, and COVID-19\u2013specific medical treatments) were quantified. Clinical outcomes of interest included in-hospital mortality, 60-day mortality, and 30-day readmissions. Outcomes were assessed with multivariable random effects logistic regression models to estimate the association of race with outcomes not attributable to known mediators, such as socioeconomic status and age, while adjusting for potential confounding between outcomes and mediators.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 43\u202f222 veterans (12\u202f135 Black veterans [28.1%]; 31\u202f087 White veterans [71.9%]; 40\u202f717 [94.2%] men) with a median (IQR) age of 71 (62-77) years who were hospitalized with SARS-CoV-2 infection were included. Controlling for site of treatment, Black patients were equally likely to be admitted to the ICU (4806 Black patients [39.6%] vs 13\u202f427 White patients [43.2%]; within-center adjusted odds ratio [aOR], 0.95; 95% CI, 0.88-1.02; P<\/jats:italic>\u2009=\u2009.17). Two-thirds of patients treated with supplemental oxygen or noninvasive or invasive mechanical ventilation also received systemic steroids, but Black veterans were less likely to receive steroids (within-center aOR, 0.88; 95% CI, 0.80-0.96; P<\/jats:italic>\u2009=\u2009.004; between-center aOR, 0.67; 95% CI, 0.48-0.96; P<\/jats:italic>\u2009=\u2009.03). Similarly, Black patients were less likely to receive remdesivir (within-center aOR, 0.89; 95% CI, 0.83-0.95; P<\/jats:italic>\u2009&amp;lt;\u2009.001; between-center aOR, 0.68; 95% CI, 0.47-0.99; P<\/jats:italic>\u2009=\u2009.02) or treatment with immunomodulatory drugs (within-center aOR, 0.77; 95% CI, 0.67-0.87; P<\/jats:italic>\u2009&amp;lt;\u2009.001). After adjusting for patient demographic characteristics, chronic health conditions, severity of acute illness, and receipt of COVID-19\u2013specific treatments, there was no association of Black race with hospital mortality (within-center aOR, 0.98; 95% CI, 0.86-1.10; P<\/jats:italic>\u2009=\u2009.71) or 30-day readmission (within-center aOR, 0.95; 95% CI, 0.88-1.04; P<\/jats:italic>\u2009=\u2009.28).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that Black veterans hospitalized with COVID-19 were less likely to be treated with evidence-based COVID-19 treatments, including systemic steroids, remdesivir, and immunomodulatory drugs.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.38507","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T15:07:42Z","timestamp":1666710462000},"page":"e2238507","source":"Crossref","is-referenced-by-count":14,"title":["Variation in Clinical Treatment and Outcomes by Race Among US Veterans Hospitalized With COVID-19"],"prefix":"10.1001","volume":"5","author":[{"given":"Alexander D.","family":"Castro","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian B.","family":"Mayr","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"},{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor B.","family":"Talisa","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"},{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obaid S.","family":"Shaikh","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"},{"name":"Division of Gastroenterology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[{"name":"Institute for Global Health, Yale University, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Yende","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"},{"name":"Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeel A.","family":"Butt","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"},{"name":"Department of Medicine, Weill Cornell Medicine, Doha, Qatar"},{"name":"Department of Population Health Sciences, Weill Cornell Medicine, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"3","key":"zoi221088r1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M20-6306","article-title":"Racial and ethnic disparities in COVID-19\u2013related infections, hospitalizations, and deaths: a systematic review.","volume":"174","author":"Mackey","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi221088r2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003807","article-title":"Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: a population-based cohort study.","volume":"18","author":"Ioannou","year":"2021","journal-title":"PLoS Med"},{"issue":"10077","key":"zoi221088r3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions.","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"zoi221088r4","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1513\/AnnalsATS.202011-1448OC","article-title":"Association of race and ethnicity with COVID-19 test positivity and hospitalization is mediated by socioeconomic factors.","volume":"18","author":"Gershengorn","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"zoi221088r5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7326\/M20-6979","article-title":"Racial disparities in COVID-19 testing and outcomes: retrospective cohort study in an integrated health system.","volume":"174","author":"Escobar","year":"2021","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi221088r6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-135-2-200107170-00012","article-title":"Adjustments for center in multicenter studies: an overview.","volume":"135","author":"Localio","year":"2001","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi221088r7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1377\/hlthaff.2020.00901","article-title":"Critical care and emergency department response at the epicenter of the COVID-19 pandemic.","volume":"39","author":"Uppal","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"46","key":"zoi221088r8","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.15585\/mmwr.mm7046a5","article-title":"Impact of hospital strain on excess deaths during the COVID-19 pandemic\u2014United States, July 2020-July 2021.","volume":"70","author":"French","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi221088r9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jpedsurg.2020.06.024","article-title":"Limiting hospital resources for acute appendicitis in children: lessons learned from the U.S. epicenter of the COVID-19 pandemic.","volume":"56","author":"Kvasnovsky","year":"2021","journal-title":"J Pediatr Surg"},{"issue":"1","key":"zoi221088r10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/ice.2021.362","article-title":"The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network.","volume":"43","author":"Weiner-Lastinger","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"zoi221088r11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/ice.2021.70","article-title":"Coronavirus disease 2019 (COVID-19) pandemic, central-line\u2013associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts.","volume":"43","author":"Fakih","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"zoi221088r12","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/cid\/ciab688","article-title":"The impact of COVID-19 on healthcare-associated infections.","volume":"74","author":"Baker","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi221088r13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi221088r14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"zoi221088r15","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19.","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi221088r16","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19\u2014final report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi221088r17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cid\/ciab419","article-title":"Trends over time in the risk of adverse outcomes among patients with severe acute respiratory syndrome coronavirus 2 infection.","volume":"74","author":"Ioannou","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi221088r18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13613-020-00692-6","article-title":"Caution about early intubation and mechanical ventilation in COVID-19.","volume":"10","author":"Tobin","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"3","key":"zoi221088r19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.15585\/mmwr.mm7103e1","article-title":"Racial and ethnic disparities in receipt of medications for treatment of COVID-19\u2014United States, March 2020-August 2021.","volume":"71","author":"Wiltz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"zoi221088r20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMc2200415","article-title":"Effectiveness of homologous or heterologous COVID-19 boosters in veterans.","volume":"386","author":"Mayr","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi221088r21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.7326\/M21-1577","article-title":"SARS-CoV-2 vaccine effectiveness in a high-risk national population in a real-world setting.","volume":"174","author":"Butt","year":"2021","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi221088r22","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1093\/cid\/ciab1023","article-title":"Rate and risk factors for severe\/critical disease among fully vaccinated persons with breakthrough SARS-CoV-2 infection in a high-risk national population.","volume":"75","author":"Butt","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi221088r23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S2213-2600(21)00380-5","article-title":"COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): a prospective cohort study.","volume":"9","author":"Agrawal","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"1","key":"zoi221088r24","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1093\/cid\/ciac178","article-title":"Vaccine effectiveness of 3 versus 2 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in a high-risk national population.","volume":"75","author":"Butt","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"zoi221088r25","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1161\/01.STR.0000135225.80898.1c","article-title":"Charlson Index comorbidity adjustment for ischemic stroke outcome studies.","volume":"35","author":"Goldstein","year":"2004","journal-title":"Stroke"},{"issue":"12","key":"zoi221088r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243028","article-title":"The effect of area deprivation on COVID-19 risk in Louisiana.","volume":"15","author":"K C","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"zoi221088r27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0006-341X.1999.00470.x","article-title":"An empirical comparison of several clustered data approaches under confounding due to cluster effects in the analysis of complications of coronary angioplasty.","volume":"55","author":"Berlin","year":"1999","journal-title":"Biometrics"},{"issue":"7","key":"zoi221088r28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1377\/hlthaff.2020.00598","article-title":"Disparities In outcomes among COVID-19 patients in a large health care system in California.","volume":"39","author":"Azar","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"16","key":"zoi221088r29","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19.","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"zoi221088r30","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe COVID-19 pneumonia.","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi221088r31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(21)00485-0","article-title":"Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DISCOVERY): a phase 3, randomised, controlled, open-label trial.","volume":"22","author":"Ader","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"10339","key":"zoi221088r32","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.","volume":"399","author":"Consortium","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"zoi221088r33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/CCM.0b013e3181c8fd58","article-title":"Do hospitals provide lower quality of care to Black patients for pneumonia?","volume":"38","author":"Mayr","year":"2010","journal-title":"Crit Care Med"},{"key":"zoi221088r34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069775","article-title":"Racial bias and reproducibility in pulse oximetry among medical and surgical inpatients in general care in the Veterans Health Administration 2013-19: multicenter, retrospective cohort study.","volume":"378","author":"Valbuena","year":"2022","journal-title":"BMJ"},{"issue":"25","key":"zoi221088r35","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMc2029240","article-title":"Racial bias in pulse oximetry measurement.","volume":"383","author":"Sjoding","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi221088r36","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/jamainternmed.2022.1906","article-title":"Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility among patients with COVID-19.","volume":"182","author":"Fawzy","year":"2022","journal-title":"JAMA Intern Med"},{"key":"zoi221088r37","unstructured":"Department of Veterans Affairs. COVID-19 response plan. Updated March 23, 2020. Accessed August 12, 2022. https:\/\/www.va.gov\/opa\/docs\/VHA_COVID_19_03232020_vF_1.pdf"},{"key":"zoi221088r38","unstructured":"Gangopadhyaya? A. Do Black and White patients experience similar rates of adverse safety events at the same hospital? Urban Institute. July 2021. Accessed September 21, 2022. https:\/\/www.urban.org\/sites\/default\/files\/publication\/104559\/do-black-and-white-patients-experience-similar-rates-of-adverse-safety-events-at-the-same-hospital_0.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797623\/castro_2022_oi_221088_1666016855.04123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T15:07:45Z","timestamp":1666710465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.38507","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}